Erratum: Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function

The Original Article was published on 06 March 2017

Correction to: Acta Pharmacologica Sinica (2017) 38, 734; doi:10.1038/aps.2016.168; published online 6 March 2017

Bin Xu#, Yan-li Li#, Ming Xu, Chang-chun Yu, Meng-qiao Lian, Ze-yao Tang, Chuan-xun Li, Yuan Lin*

Acta Pharmacol Sin 2017; 38 (5): 688–98.

The concentration of geniposide (25–100 μmol/L) in PubMed is wrong.

The correct concentration is geniposide (25–100 μg/mL).

The editors are sorry for the error.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Yuan Lin.

Additional information

The online version of the original article can be found at 10.1038/aps.2016.168

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Xu, B., Li, Yl., Xu, M. et al. Erratum: Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function. Acta Pharmacol Sin 38, 734 (2017). https://doi.org/10.1038/aps.2017.41

Download citation

Search

Quick links